JP2024516818A5 - - Google Patents
Info
- Publication number
- JP2024516818A5 JP2024516818A5 JP2023565954A JP2023565954A JP2024516818A5 JP 2024516818 A5 JP2024516818 A5 JP 2024516818A5 JP 2023565954 A JP2023565954 A JP 2023565954A JP 2023565954 A JP2023565954 A JP 2023565954A JP 2024516818 A5 JP2024516818 A5 JP 2024516818A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- amino acid
- acid sequence
- antibody
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CA2021/050572 WO2022226623A1 (en) | 2021-04-27 | 2021-04-27 | Method for allowing immune cells infiltration in tumors |
| CAPCT/CA2021/050572 | 2021-04-27 | ||
| PCT/CA2022/050632 WO2022226637A1 (en) | 2021-04-27 | 2022-04-26 | Method for allowing immune cells infiltration in tumors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024516818A JP2024516818A (ja) | 2024-04-17 |
| JP2024516818A5 true JP2024516818A5 (https=) | 2025-05-08 |
Family
ID=83846453
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023566662A Pending JP2024516416A (ja) | 2021-04-27 | 2021-04-27 | 腫瘍への免疫細胞浸潤を可能にするための方法 |
| JP2023565954A Pending JP2024516818A (ja) | 2021-04-27 | 2022-04-26 | 腫瘍への免疫細胞浸潤を可能にするための方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023566662A Pending JP2024516416A (ja) | 2021-04-27 | 2021-04-27 | 腫瘍への免疫細胞浸潤を可能にするための方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20240199758A1 (https=) |
| EP (2) | EP4329801A4 (https=) |
| JP (2) | JP2024516416A (https=) |
| KR (2) | KR20240014052A (https=) |
| CN (2) | CN117479955A (https=) |
| AU (2) | AU2021442702A1 (https=) |
| CA (2) | CA3173786A1 (https=) |
| IL (2) | IL307954A (https=) |
| MX (2) | MX2023012766A (https=) |
| WO (2) | WO2022226623A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3173786A1 (en) * | 2021-04-27 | 2022-10-27 | Mario Filion | Method for allowing immune cells infiltration in tumors |
| MX2024009671A (es) * | 2022-02-07 | 2024-08-19 | Alethia Biotherapeutics Inc | Terapia de combinación para uso en el tratamiento del cáncer de pulmón de células no pequeñas. |
| CN118914553B (zh) * | 2024-07-22 | 2025-03-18 | 西安医学院第一附属医院 | 一种结直肠腺瘤和结直肠癌早期筛查的生物标志物的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1882A (en) | 1872-12-11 | Angus. Campbell | A towel hanger | |
| ES2543341T3 (es) | 2005-09-13 | 2015-08-18 | National Research Council Of Canada | Métodos y composiciones para modular la actividad de células tumorales |
| EA034462B1 (ru) | 2009-11-24 | 2020-02-11 | Алетиа Байотерапьютикс Инк. | Антикластериновые антитела и антигенсвязывающие фрагменты и их использование для уменьшения объема новообразований |
| US9822170B2 (en) * | 2012-02-22 | 2017-11-21 | Alethia Biotherapeutics Inc. | Co-use of a clusterin inhibitor with an EGFR inhibitor to treat cancer |
| CA3173786A1 (en) * | 2021-04-27 | 2022-10-27 | Mario Filion | Method for allowing immune cells infiltration in tumors |
-
2021
- 2021-04-27 CA CA3173786A patent/CA3173786A1/en active Pending
- 2021-04-27 AU AU2021442702A patent/AU2021442702A1/en active Pending
- 2021-04-27 EP EP21938161.3A patent/EP4329801A4/en active Pending
- 2021-04-27 KR KR1020237040576A patent/KR20240014052A/ko active Pending
- 2021-04-27 CN CN202180099369.0A patent/CN117479955A/zh active Pending
- 2021-04-27 US US18/287,327 patent/US20240199758A1/en active Pending
- 2021-04-27 MX MX2023012766A patent/MX2023012766A/es unknown
- 2021-04-27 IL IL307954A patent/IL307954A/en unknown
- 2021-04-27 WO PCT/CA2021/050572 patent/WO2022226623A1/en not_active Ceased
- 2021-04-27 JP JP2023566662A patent/JP2024516416A/ja active Pending
-
2022
- 2022-04-26 US US18/287,331 patent/US20240317884A1/en active Pending
- 2022-04-26 CA CA3173797A patent/CA3173797A1/en active Pending
- 2022-04-26 AU AU2022266854A patent/AU2022266854A1/en active Pending
- 2022-04-26 IL IL307961A patent/IL307961A/en unknown
- 2022-04-26 MX MX2023012768A patent/MX2023012768A/es unknown
- 2022-04-26 JP JP2023565954A patent/JP2024516818A/ja active Pending
- 2022-04-26 KR KR1020237040565A patent/KR20240013743A/ko active Pending
- 2022-04-26 WO PCT/CA2022/050632 patent/WO2022226637A1/en not_active Ceased
- 2022-04-26 EP EP22794137.4A patent/EP4329802A4/en active Pending
- 2022-04-26 CN CN202280042256.1A patent/CN117479956A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Tarantino et al. | Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies | |
| JP2024516818A5 (https=) | ||
| Singh et al. | TNBC: potential targeting of multiple receptors for a therapeutic breakthrough, nanomedicine, and immunotherapy | |
| Lee | Chemotherapy for lung cancer in the era of personalized medicine | |
| Zhang et al. | Systemic treatment of advanced or recurrent biliary tract cancer | |
| Oronsky et al. | What's new in SCLC? A review | |
| Herreros-Villanueva et al. | Adjuvant and neoadjuvant treatment in pancreatic cancer | |
| Satoh et al. | Randomized phase II trial of nimotuzumab plus irinotecan versus irinotecan alone as second-line therapy for patients with advanced gastric cancer | |
| JP2021169479A5 (https=) | ||
| IL294800A (en) | Methods for treatment of cancer with an anti-tigit antagonist antibody | |
| Harada et al. | Global chemotherapy development for gastric cancer | |
| ES2656168T3 (es) | Anticuerpo anti cadherina marcado con un metal radioactivo | |
| Aoki et al. | Trastuzumab deruxtecan for the treatment of HER2-positive advanced gastric cancer: a clinical perspective | |
| Rebelo et al. | Pancreatic cancer therapy review: from classic therapeutic agents to modern nanotechnologies | |
| Davidson et al. | Current and future therapies for advanced gastric cancer | |
| RU2010151602A (ru) | Комбинированная терапия с помощью рм00104 и другого противоопухолевого средства | |
| JP2011520921A5 (https=) | ||
| Yusoh et al. | Advances in platinum-based cancer therapy: overcoming platinum resistance through rational combinatorial strategies | |
| Mosquera et al. | Molecular targeted therapy for pancreatic adenocarcinoma: A review of completed and ongoing late phase clinical trials | |
| JP2021511372A5 (https=) | ||
| JP2021502334A5 (https=) | ||
| JP2024545427A5 (https=) | ||
| Lu et al. | Exploring the therapeutic potential of ADC combination for triple-negative breast cancer | |
| Roviello et al. | Maintenance in gastric cancer: New life for an old issue? | |
| Saltos et al. | Breaking the impasse: advances in treatment of small cell lung cancer |